Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Martin E. Gore
Publisher Correction: Clinical Activity and Molecular Correlates of Response to Atezolizumab Alone or in Combination With Bevacizumab Versus Sunitinib in Renal Cell Carcinoma
Nature Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
Therapeutic Advances in Urology
Urology
Related publications
Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma in Vivo With Susceptibility Contrast MRI
Cancer Research
Cancer Research
Oncology
Sunitinib Causes Macrocytosis in Patients With Advanced Renal Cell Carcinoma
Current Oncology
Oncology
Publisher Correction: Renal Capsular Invasion Is a Prognostic Biomarker in Localized Clear Cell Renal Cell Carcinoma
Scientific Reports
Multidisciplinary
A Case of Metastatic Renal Cell Carcinoma and Bile Duct Carcinoma Treated With a Combination of Sunitinib and Gemcitabine
BMC Cancer
Cancer Research
Oncology
Genetics
Cost-Effectiveness and Cost-Utility Analysis of Sunitinib Versus Sorafenib and Bevacizumab + Interferon-Alfa as First-Line Treatment for Metastatic Renal Cell Carcinoma in Ecuador
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Bevacizumab, Sorafenib Tosylate, Sunitinib and Temsirolimus for Renal Cell Carcinoma: A Systematic Review and Economic Evaluation
Health Technology Assessment
Medicine
Health Policy
Cox-2 Inhibition Enhances the Activity of Sunitinib in Human Renal Cell Carcinoma Xenografts
British Journal of Cancer
Cancer Research
Oncology
